GM Turino, AF Barker, ML Brantly, AB Cohen, RP Connelly, RG Crystal, E Eden, MD Schluchter and JK Stoller
Department of Medicine, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians & Surgeons, New York, NY 10019, USA.

This report describes the clinical characteristics of a group of 59 individuals with the PI*SZ phenotype and alpha 1-antitrypsin (alpha 1- AT) deficiency, identified during recruitment of a registry for subjects with severe alpha 1-antitrypsin deficiency. Currently, 1,129 individuals with levels of alpha 1-AT of 11 microM or below have been enrolled in this registry. Individuals with the SZ phenotype whose alpha 1-AT levels are at or below 11 microM will be followed in the registry; those whose levels exceeded 11 microM had baseline studies and are included in this report. Baseline pulmonary function tests included spirometry before and after an inhaled bronchodilator, diffusing capacity for carbon monoxide (DLCO), and chest roentgenograms. Among nonsmokers, subjects with the SZ phenotype demonstrated airflow obstruction less frequently than those with with the ZZ phenotype. Among ex- and current smokers, the frequency and severity of airflow obstruction was similar between SZ and ZZ subjects. Individuals with the SZ phenotype reported respiratory symptoms less frequently than did ZZ subjects. Overall, airflow obstruction was less common and milder among PI*SZ than PI*ZZ subjects. Cigarette smoking correlated more strongly with airflow obstruction among PI*SZ than PI*ZZ subjects. These observations indicate that in smokers, the PI*SZ phenotype confers a significant risk of the development of chronic obstructive pulmonary disease (COPD). Of itself, except in rare instances in nonsmoking individuals, the PI*SZ phenotype may confer little or no added risk of developing COPD.

This article has been cited by other articles:

				D. K. Hogarth and G. Rachelefsky Screening and Familial Testing of Patients for {alpha}1-Antitrypsin Deficiency Chest, April 1, 2008; 133(4): 981 - 988. [Abstract] [Full Text] [PDF]

				J. Prins, B. B. van der Meijden, R. J. Kraaijenhagen, and J. P.M. Wielders Inherited Chronic Obstructive Pulmonary Disease: New Selective-Sequencing Workup for {alpha}1-Antitrypsin Deficiency Identifies 2 Previously Unidentified Null Alleles Clin. Chem., January 1, 2008; 54(1): 101 - 107. [Abstract] [Full Text] [PDF]

				J. K. Stoller, T. R. Gildea, A. L. Ries, Y. M. Meli, M. T. Karafa, and National Emphysema Treatment Trial Research Group Lung Volume Reduction Surgery in Patients With Emphysema and {alpha}-1 Antitrypsin Deficiency Ann. Thorac. Surg., January 1, 2007; 83(1): 241 - 251. [Abstract] [Full Text] [PDF]

				M. R. Snyder, J. A. Katzmann, M. L. Butz, P. Yang, D. B. Dawson, K. C. Halling, W. E. Highsmith, and S. N. Thibodeau Diagnosis of {alpha}-1-Antitrypsin Deficiency: An Algorithm of Quantification, Genotyping, and Phenotyping Clin. Chem., December 1, 2006; 52(12): 2236 - 2242. [Abstract] [Full Text] [PDF]

				O. Senn, E. W. Russi, M. Imboden, and N. M. Probst-Hensch {alpha}1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants Eur. Respir. J., November 1, 2005; 26(5): 909 - 917. [Abstract] [Full Text] [PDF]

				M. Dahl, C. P. Hersh, N. P. Ly, C. S. Berkey, E. K. Silverman, and B. G. Nordestgaard The protease inhibitor PI*S allele and COPD: a meta-analysis Eur. Respir. J., July 1, 2005; 26(1): 67 - 76. [Abstract] [Full Text] [PDF]

				I Ferrarotti, J Baccheschi, M Zorzetto, C Tinelli, L Corda, B Balbi, I Campo, E Pozzi, G Faa, P Coni, et al. Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency J. Med. Genet., March 1, 2005; 42(3): 282 - 287. [Full Text] [PDF]

				C P Hersh, M Dahl, N P Ly, C S Berkey, B G Nordestgaard, and E K Silverman Chronic obstructive pulmonary disease in {alpha}1-antitrypsin PI MZ heterozygotes: a meta-analysis Thorax, October 1, 2004; 59(10): 843 - 849. [Abstract] [Full Text] [PDF]

				N. A. Molfino Genetics of COPD Chest, May 1, 2004; 125(5): 1929 - 1940. [Abstract] [Full Text] [PDF]

				D L DeMeo and E K Silverman {alpha}1-Antitrypsin deficiency {middle dot} 2: Genetic aspects of {alpha}1-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk Thorax, March 1, 2004; 59(3): 259 - 264. [Abstract] [Full Text] [PDF]

				American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 818 - 900. [Full Text] [PDF]

				A. L. Chan, S. Kwack, K. D. Jones, M. K. Glassberg, and C. R. Gherman Lymphangioleiomyomatosis and SZ {alpha}1-Antitrypsin Disease: A Unique Combination? Chest, August 1, 2003; 124(2): 763 - 765. [Abstract] [Full Text] [PDF]

				P Ferenci How to identify the genetic basis of gastrointestinal and liver diseases? Gut, May 1, 2003; 52(90002): ii6 - 9. [Abstract] [Full Text]

				G M Corbo, F Forastiere, N Agabiti, V Dell'Orco, R Pistelli, G Massi, C A Perucci, and S Valente Passive smoking and lung function in {alpha}1-antitrypsin heterozygote schoolchildren Thorax, March 1, 2003; 58(3): 237 - 241. [Abstract] [Full Text] [PDF]

				F. J. de Serres Worldwide Racial and Ethnic Distribution of {alpha}1-Antitrypsin Deficiency: Summary of an Analysis of Published Genetic Epidemiologic Surveys Chest, November 1, 2002; 122(5): 1818 - 1829. [Abstract] [Full Text] [PDF]

				A J Sandford and E K Silverman Chronic obstructive pulmonary disease * 1: Susceptibility factors for COPD the genotype-environment interaction Thorax, August 1, 2002; 57(8): 736 - 741. [Abstract] [Full Text] [PDF]

				R. W. Carrell and D. A. Lomas Alpha1-Antitrypsin Deficiency -- A Model for Conformational Diseases N. Engl. J. Med., January 3, 2002; 346(1): 45 - 53. [Full Text] [PDF]

				R.A. Stockley and E.J. Campbell Alpha-1-antitrypsin genotyping with mouthwash specimens Eur. Respir. J., March 1, 2001; 17(3): 356 - 359. [Abstract] [Full Text] [PDF]

				M. Dahl, B. G. Nordestgaard, P. Lange, J. Vestbo, and A. Tybjarg-Hansen Molecular Diagnosis of Intermediate and Severe {{alpha}}1-Antitrypsin Deficiency: MZ Individuals with Chronic Obstructive Pulmonary Disease May Have Lower Lung Function Than MM Individuals Clin. Chem., January 1, 2001; 47(1): 56 - 62. [Abstract] [Full Text] [PDF]

				R A Stockley Alpha-1-antitrypsin deficiency: what next? Thorax, July 1, 2000; 55(7): 614 - 618. [Full Text]

				A. J. SANDFORD, T. CHAGANI, J. J. SPINELLI, and P. D. PARE alpha 1-Antitrypsin Genotypes and the Acute-phase Response to Open Heart Surgery Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1624 - 1628. [Abstract] [Full Text] [PDF]

				P. J Barnes Genetics and pulmonary medicine bullet  9: Molecular genetics of chronic obstructive pulmonary disease Thorax, March 1, 1999; 54(3): 245 - 252. [Full Text]

				A. J. Sandford, T. D. Weir, J. J. Spinelli, and P. D. Paré Z and S Mutations of the alpha 1-Antitrypsin Gene and the Risk of Chronic Obstructive Pulmonary Disease Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 287 - 291. [Abstract] [Full Text]

				G. R. Epler and E. J. Mark Case 11-1998- A 35-Year-Old Woman with Obstructive Pulmonary Disease and Cystic Changes on CT Scans of the Chest N. Engl. J. Med., April 9, 1998; 338(15): 1051 - 1058. [Full Text] [PDF]

				R. M. SENIOR and N. R. ANTHONISEN Chronic Obstructive Pulmonary Disease (COPD) Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S139 - S147. [Full Text] [PDF]